Cystic Fibrosis in Focus
by ReachMD
February 7, 2020 12:19 am
Cystic fibrosis (CF) is one of the most prevalent global congenital disorders, affecting some 70,000 individuals worldwide and 30,000 children and adults in the United States. While clinical efforts are expanding worldwide to improve diagnostic testing and treatment approaches for this progressive lung disease, targeted therapies for CF against any specific mutation remain elusive. The Cystic Fibrosis in Focus series gathers the latest information from leading medical experts devoted to advancing knowledge in pursuit of treating patients with CF. With education spanning topics such as pinpointing CF’s underlying genetic basis, identifying specific mutations, improving clinical detection methods, and providing more targeted therapies, The Cystic Fibrosis in Focus series delivers the critical tools needed to improve care for CF patients. In Partnership with
Recent Episodes
An In-Depth Look at the Evolution of Cystic Fibrosis Treatments
4 years agoJournal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
8 years agoJournal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
8 years agoCell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
8 years ago